These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16764756)

  • 1. The way forward: new drugs and new therapeutic strategies in lung cancer therapy.
    Scagliotti GV; Novello S
    Clin Lung Cancer; 2006 May; 7 Suppl 4():S109-10. PubMed ID: 16764756
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis inhibitors for lung cancer: clinical developments and future directions.
    Blumenschein G; Heymach JV
    J Thorac Oncol; 2006 Sep; 1(7):744-8. PubMed ID: 17409952
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted therapy and new anticancer drugs in advanced disease.
    Silva S; Danson S
    Thorac Surg Clin; 2013 Aug; 23(3):411-9. PubMed ID: 23931023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iressa : first angiogenesis inhibitor approved for the treatment of advanced NSCLC.
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):257. PubMed ID: 12820770
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapies and non-small-cell lung cancer: work in progress?
    Gridelli C
    Curr Opin Oncol; 2006 Mar; 18(2):132-4. PubMed ID: 16462181
    [No Abstract]   [Full Text] [Related]  

  • 6. [New advance of the molecular targeting agents in advanced non-small cell lung cancer].
    Zhang L; Cheng ZW; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):323-9. PubMed ID: 15266840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
    Carbognin L; Pilotto S; Peretti U; Tortora G; Bria E
    Expert Opin Investig Drugs; 2016 Jun; 25(6):635-8. PubMed ID: 27054716
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted therapies in the treatment of non small cell lung cancer: reality and hopes.
    Gridelli C
    Curr Opin Oncol; 2004 Mar; 16(2):126-9. PubMed ID: 15075903
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiangiogenic agents.
    Stani SC; Capaccetti B; Bonginelli P; Sarmiento R; De Sio L; Fanelli M; Gasparini G
    Suppl Tumori; 2002; 1(4):S39-43. PubMed ID: 12415816
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label uses of bevacizumab: breast and lung cancer indications.
    Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(8):1-4. PubMed ID: 17061398
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel approaches for the treatment of non-small cell lung cancer.
    Bonomi P
    Semin Oncol; 2001 Aug; 28(4 Suppl 14):45-9. PubMed ID: 11605183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the future of non-small cell lung cancer treatment.
    Ramalingam S
    Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bevacizumab in the treatment of non-small cell lung cancer].
    Knuuttila A; Rouhos A; Karjalainen EM; Riska H; Pietiläinen M; Paunu N; Salomaa ER
    Duodecim; 2009; 125(4):361-8. PubMed ID: 19358416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted therapies for lung cancer].
    Tamura K
    Rinsho Ketsueki; 2008 Aug; 49(8):616-21. PubMed ID: 18800610
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer.
    Reckamp KL
    Cancer Lett; 2012 Aug; 321(2):101-9. PubMed ID: 22306704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.
    Nguewa PA; Calvo A; Pullamsetti SS; Banat GA; Grimminger F; Savai R
    Expert Opin Investig Drugs; 2011 Jan; 20(1):61-74. PubMed ID: 21142806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel agents in the treatment of non-small cell lung cancer: implications for neoadjuvant chemotherapy?
    Bergqvist M; Henriksson R; Brattström D
    In Vivo; 2005; 19(3):523-33. PubMed ID: 15875771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapies for non-small cell lung cancer].
    Ostoros G; Kovács G; Szondy K; Döme B
    Orv Hetil; 2005 May; 146(21):1135-41. PubMed ID: 15991677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell lung cancer and targeted therapies.
    Blackhall FH; Shepherd FA
    Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.